[The prevalence of serum anti-hepatitis C virus antibodies in hemodialyzed patients]. 1991

M Motta, and R Brischetto, and F Rapisarda, and C Corno, and C Rapisarda, and P Fatuzzo, and A Messina, and A Biondi, and E Mezzasalma, and G Calcara
Cattedra di Nefrologia Chirurgica, Università degli Studi di Catania.

Hepatitis C virus (HCV) is responsible for a high percentage of cases of transfusional hepatitis and is often considered the etiological agent of numerous cases of non-A, non-B hepatitis in which parenteral transmission has not been documented. Patients undergoing hemodialysis are at risk for HCV infection. We used an immunoenzymatic method and confirmatory test (neutralization test) to determine serum anti-HCV antibody positivity in order to identify the factors associated with increased risk of HCV infection. We studied 63 hemodialyzed patients from eastern Sicily and compared the mean dialytic age and transfusion case history in positive and negative groups. 17.4 percent of the patients were anti-HCV positive. Mean dialytic age was significantly higher in the anti-HCV positive group. On the contrary no significant differences regarding transfusion case history or number of units of blood transfused were seen in the two groups. Our study confirms that hemodialyzed patients are at risk for HCV infection. This risk seems to increase with dialytic age. The lack of correlation between HCV and transfusion case history suggests that it may be a hospital-acquired infection.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012802 Sicily An island located in the Mediterranean Sea and governed by Italy,
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

M Motta, and R Brischetto, and F Rapisarda, and C Corno, and C Rapisarda, and P Fatuzzo, and A Messina, and A Biondi, and E Mezzasalma, and G Calcara
January 2007, Revista da Sociedade Brasileira de Medicina Tropical,
M Motta, and R Brischetto, and F Rapisarda, and C Corno, and C Rapisarda, and P Fatuzzo, and A Messina, and A Biondi, and E Mezzasalma, and G Calcara
August 1995, Vnitrni lekarstvi,
M Motta, and R Brischetto, and F Rapisarda, and C Corno, and C Rapisarda, and P Fatuzzo, and A Messina, and A Biondi, and E Mezzasalma, and G Calcara
July 1992, Orvosi hetilap,
M Motta, and R Brischetto, and F Rapisarda, and C Corno, and C Rapisarda, and P Fatuzzo, and A Messina, and A Biondi, and E Mezzasalma, and G Calcara
January 1992, Medicina,
M Motta, and R Brischetto, and F Rapisarda, and C Corno, and C Rapisarda, and P Fatuzzo, and A Messina, and A Biondi, and E Mezzasalma, and G Calcara
January 1992, Nephron,
M Motta, and R Brischetto, and F Rapisarda, and C Corno, and C Rapisarda, and P Fatuzzo, and A Messina, and A Biondi, and E Mezzasalma, and G Calcara
February 2007, The International journal of artificial organs,
M Motta, and R Brischetto, and F Rapisarda, and C Corno, and C Rapisarda, and P Fatuzzo, and A Messina, and A Biondi, and E Mezzasalma, and G Calcara
January 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Motta, and R Brischetto, and F Rapisarda, and C Corno, and C Rapisarda, and P Fatuzzo, and A Messina, and A Biondi, and E Mezzasalma, and G Calcara
June 1993, Kidney international. Supplement,
M Motta, and R Brischetto, and F Rapisarda, and C Corno, and C Rapisarda, and P Fatuzzo, and A Messina, and A Biondi, and E Mezzasalma, and G Calcara
October 2000, Multiple sclerosis (Houndmills, Basingstoke, England),
M Motta, and R Brischetto, and F Rapisarda, and C Corno, and C Rapisarda, and P Fatuzzo, and A Messina, and A Biondi, and E Mezzasalma, and G Calcara
January 1997, Gastroenterologie clinique et biologique,
Copied contents to your clipboard!